Location History:
- Cleveland, OH (US) (2018)
- South Euclid, OH (US) (2003 - 2019)
Company Filing History:
4 out of 1,313 
2 out of 2 
1 out of 3,025 
Years Active: 2003-2019
Title: Laurie Dudik: Innovator in Cancer Detection Technologies
Introduction
Laurie Dudik is a prominent inventor based in South Euclid, OH (US). She has made significant contributions to the field of cancer detection, holding a total of 8 patents. Her innovative work focuses on developing systems that enhance the detection of specific proteins associated with various types of cancer.
Latest Patents
One of her latest patents is a system and method for detecting alpha-methylacyl-CoA racemase (AMACR) and prostate cancer. This detection system determines AMACR levels in bodily samples through a reaction solution that generates hydrogen peroxide (HO) upon interaction with AMACR. The solution includes a (2R)-2-methylacyl-CoA epimer, which AMACR can chirally invert to a (2S)-2-methylacyl-CoA epimer, facilitating the detection process.
Another notable patent involves a system and method for detecting lysyl oxidase-like 2 protein (LOXL2) and breast cancer. This system also generates hydrogen peroxide (HO) in the presence of LOXL2 in bodily samples. The reaction solution contains lysine, which LOXL2 can oxidatively deaminate to produce α-aminoadipic-δ-semialdehyde (allysine) and hydrogen peroxide, aiding in the detection of breast cancer.
Career Highlights
Laurie has worked with esteemed institutions such as Case Western Reserve University and Hathaway Brown School. Her experience in these organizations has contributed to her expertise in cancer research and detection technologies.
Collaborations
Throughout her career, Laurie has collaborated with notable colleagues, including Chung-Chiun Liu and Jesse S. Wainright. These partnerships have furthered her research and development efforts in the field of cancer detection.
Conclusion
Laurie Dudik's innovative contributions to cancer detection technologies highlight her role as a leading inventor in this critical area of research. Her patents reflect a commitment to improving diagnostic methods for cancer, ultimately benefiting patients and the medical community.